About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Compounds That Block Reactivation of Latent HIV-1 Discovered

by Colleen Fleiss on December 5, 2018 at 10:12 AM
Font : A-A+

Compounds That Block Reactivation of Latent HIV-1 Discovered

Compounds that block the reactivation of latent HIV-1 in a human cell line containing the latent virus have been discovered by a team of investigators from the University of Pittsburgh. The research is published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.

The compounds the researchers tested came from a library of 418 different "kinase inhibitors." These pathways apparently include ones that can reverse latency of HIV-1 virus that has become integrated into the human genome. Thus, the research could lead to ways to permanently suppress HIV infections, said Benni E. Vargas, a Ph.D. student in Microbiology and Immunology at the University of Pittsburgh School of Medicine.

Advertisement


The researchers had infected the cell line with HIV-1 that then became dormant within the cells. The virus contained a "reporter gene," which would light up during reactivation so that the investigators would know if reactivation occurred. The cell cultures were then given an HIV-1 activating small molecule compound, and each culture was exposed to one of the 418 different kinase inhibitors.

"There's a need to understand the mechanisms and signaling pathways by which the host cell regulates HIV-1 latency and reactivation," said Mr. Vargas. "What better way to identify these host signaling pathways than to screen a whole library of drugs that target different parts of the host signaling pathway?"
Advertisement

A potential downside of the kinase inhibitors is possible toxicity to human cells, said Mr. Vargas. The investigators gauged toxicity by measuring cellular production of ATP, a compound manufactured in cells which functions as cellular fuel, within the tiny cellular motors, the mitochondria. A notable reduction in the quantity of ATP, as present, as compared to normal, would indicate toxicity, said Mr. Vargas. Twelve kinase inhibitors blocked reactivation irrespective of latency reversing agent, and two of these did so with minimal toxicity. The motivation for the research was that several other groups had previously identified inhibitors of kinases that block reactivation of the dormant HIV-1 provirus, said Mr. Vargas.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Health Benefits of Sea Buckthorn
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV...
Quiz on HIV Symptoms
Do you know that there are symptoms for each stage of HIV/AIDS? Learn more from our HIV Symptom ......
Facts on HIV / AIDS
Human Immunodeficiency Virus (HIV) usually targets the human immune system to weaken the body's ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use